Last update 18 Oct 2025

Semaglutide biosimilar (Jilin Huisheng)

Overview

Basic Info

Drug Type
Recombinant polypeptide, Biosimilar
Synonyms-
Target
GLP-1R
Action
agonists
Mechanism
GLP-1R agonists(Glucagon-like peptide 1 receptor agonists)
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Diabetes Mellitus, Type 2Obesity
Inactive Indication-
Originator Organization
Jilin Huisheng Biological Pharmaceutical Co., Ltd.
Active Organization
Jilin Huisheng Biological Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization
Jilin Huisheng Biological Pharmaceutical Co., Ltd.Beijing Meiyan Space Biomedical Co., Ltd
Drug Highest PhaseNDA/BLA
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Related

3
Clinical Trials associated with Semaglutide biosimilar (Jilin Huisheng)
CTR20232721
/ Not yet recruitingPhase 1
司美格鲁肽注射液与诺和泰®在中国健康受试者中的药代动力学及安全性的随机、开放、单剂量、平行的I期临床研究
[Translation] A randomized, open-label, single-dose, parallel phase I clinical study on the pharmacokinetics and safety of semaglutide injection and Novotec® in healthy Chinese subjects
CTR20232700
/ Not yet recruitingPhase 3
比较司美格鲁肽注射液与诺和泰®治疗2型糖尿病的有效性和安全性的多中心、随机、开放、平行对照的III期临床试验
[Translation] A multicenter, randomized, open, parallel-controlled Phase III clinical trial comparing the efficacy and safety of semaglutide injection and Novotel® in the treatment of type 2 diabetes
CTR20244146
/ Not yet recruitingPhase 3
评价司美格鲁肽注射液在成人非糖尿病肥胖患者中作为生活方式干预辅助治疗的Ⅲ期临床试验
[Translation] Phase III clinical trial evaluating semaglutide injection as an adjunct to lifestyle intervention in non-diabetic obese adults
100 Clinical Results associated with Semaglutide biosimilar (Jilin Huisheng)
Login to view more data
100 Translational Medicine associated with Semaglutide biosimilar (Jilin Huisheng)
Login to view more data
100 Patents (Medical) associated with Semaglutide biosimilar (Jilin Huisheng)
Login to view more data
100 Deals associated with Semaglutide biosimilar (Jilin Huisheng)
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
A10BJ06
-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2NDA/BLA
China
Jilin Huisheng Biological Pharmaceutical Co., Ltd.
16 Aug 2025
ObesityPhase 3
China
Jilin Huisheng Biological Pharmaceutical Co., Ltd.
07 Nov 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free